Life Extension - Milk Thistle - Certified European Milk Thistle 750mg - 120 Vegetarian Caps
Certified European Milk Thistle (Silymarin-Silibinins-Isosilybin A & B), 120 Vegetarian Capsules Item Catalog Number: 01517 Milk thistle extract has long been valued for its role in ensuring healthy liver function and it is also a powerful antioxidant. This extract consists of silibinin and other similar compounds. Until recently, researchers believed silibinin was the most biologically active ingredient in milk thistle extract. Highly advanced extraction technology has now enabled scientists to isolate silymarin constituents and test their efficacy against various cell lines. Among the compounds tested, a silymarin constituent called isosilybin B proved to be the most efficient in maintaining healthy cell division. Certified European Milk Thistle contains standardized, premium-quality potencies of silymarin, silibinin and isosilybin A and B, providing the full spectrum of milk thistle compounds that promote a healthy liver and prostate. Certified European Milk Thistle is both grown and processed in Europe. The botanical extract in Certified European Milk Thistle is a triple standardized milk thistle extract. In addition to an optimal 80% standardization of the main active compounds, silymarin flavonolignans, Certified European Milk Thistle is further standardized to three highly active isomers: silibinins, isosilybin A and isosilybin B. References 1.Am J Gastroenterol. 1998 Feb 93(2):139-43. 2. Dig Liver Dis. 2004 Nov 36(11):752-9. 3. Life Sci. 1996 58(18):1591-600. 4. Clin Cancer Res. 2005 Dec 1 11(23):8441-8. 5. Altern Med Rev. 2005 Sep 10(3):193-203. 6. Gastroenterology.. [Epub ahead of print] 7. Int J Biol Sci. 2009 Aug 11 5(6):549-57. 8. Life Sci. 2009 Aug 12 85(7-8):281-90. 9. Cell Prolif. 2009 Apr 42(2):229-40. 10. Phytomedicine. 2009 May 16(5):391-400. 11. Carcinogenesis. 2007 Jul 28(7):1533-42. 12. Int J Cancer. 2008 Jul 1 123(1):41-50. 13. Prostate Cancer Res. 2005 May 15 65(10):4448-57. 14. Oncogene. 2006 Feb 16 25(7):1053-69. 15. Cancer Lett. 2008 Oct